Yan-Fang Ye

547 total citations
7 papers, 167 citations indexed

About

Yan-Fang Ye is a scholar working on Oncology, Otorhinolaryngology and Surgery. According to data from OpenAlex, Yan-Fang Ye has authored 7 papers receiving a total of 167 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Otorhinolaryngology and 3 papers in Surgery. Recurrent topics in Yan-Fang Ye's work include Head and Neck Cancer Studies (4 papers), Viral-associated cancers and disorders (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Yan-Fang Ye is often cited by papers focused on Head and Neck Cancer Studies (4 papers), Viral-associated cancers and disorders (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Yan-Fang Ye collaborates with scholars based in China, Sweden and United States. Yan-Fang Ye's co-authors include Chao-Nan Qian, Yan‐Qun Xiang, Xiang Guo, Wei-Xiong Xia, Ka-Jia Cao, Haibo Zhang, Su-Mei Cao, Xing Lü, Lin Wang and Qing Liu and has published in prestigious journals such as Clinical Cancer Research, European Journal of Cancer and BMJ Open.

In The Last Decade

Yan-Fang Ye

7 papers receiving 166 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan-Fang Ye China 7 101 76 47 44 29 7 167
Chuanben Chen China 8 87 0.9× 74 1.0× 71 1.5× 73 1.7× 15 0.5× 29 238
N Moeckelmann Germany 4 171 1.7× 96 1.3× 110 2.3× 33 0.8× 22 0.8× 5 228
Ann Tan United States 7 50 0.5× 98 1.3× 95 2.0× 61 1.4× 53 1.8× 16 235
Miguel Pastor Borgoñón Spain 8 59 0.6× 57 0.8× 26 0.6× 30 0.7× 23 0.8× 13 144
Zhen‐Chong Yang China 7 100 1.0× 87 1.1× 51 1.1× 94 2.1× 12 0.4× 16 229
Shu‐Hui Lv China 8 125 1.2× 97 1.3× 71 1.5× 42 1.0× 15 0.5× 19 175
Tatiana Hadjieva Bulgaria 5 64 0.6× 47 0.6× 26 0.6× 61 1.4× 6 0.2× 7 154
Umair Mahmood United States 7 89 0.9× 49 0.6× 52 1.1× 72 1.6× 41 1.4× 16 200
Wei-Xiong Xia China 5 127 1.3× 101 1.3× 64 1.4× 43 1.0× 5 0.2× 5 173
Collin Brummel United States 9 71 0.7× 43 0.6× 28 0.6× 39 0.9× 36 1.2× 15 178

Countries citing papers authored by Yan-Fang Ye

Since Specialization
Citations

This map shows the geographic impact of Yan-Fang Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan-Fang Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan-Fang Ye more than expected).

Fields of papers citing papers by Yan-Fang Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan-Fang Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan-Fang Ye. The network helps show where Yan-Fang Ye may publish in the future.

Co-authorship network of co-authors of Yan-Fang Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Yan-Fang Ye. A scholar is included among the top collaborators of Yan-Fang Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan-Fang Ye. Yan-Fang Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
L, Hu, Yan‐Qun Xiang, Xing Lv, et al.. (2017). Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic area. European Journal of Cancer. 73. 48–60. 34 indexed citations
2.
Xia, Wei-Xiong, Hu L, Xing Lv, et al.. (2017). Combining cetuximab with chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: A propensity score analysis. Oral Oncology. 67. 167–174. 20 indexed citations
3.
Gao, Rui, Lin Wang, Qing Liu, et al.. (2017). Evaluation of seven recombinant VCA-IgA ELISA kits for the diagnosis of nasopharyngeal carcinoma in China: a case–control trial. BMJ Open. 7(6). e013211–e013211. 15 indexed citations
5.
Ye, Yan-Fang, Yan‐Qun Xiang, Fang Fang, et al.. (2015). Hepatitis B Virus Infection and Risk of Nasopharyngeal Carcinoma in Southern China. Cancer Epidemiology Biomarkers & Prevention. 24(11). 1766–1773. 26 indexed citations
6.
Xia, Wei-Xiong, Haibo Zhang, Xing Lü, et al.. (2013). A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment serum C-reactive protein and N-classification. European Journal of Cancer. 49(9). 2152–2160. 53 indexed citations
7.
Wen, Yue-Feng, Huai Liu, Hao-Yuan Mo, et al.. (2011). Polymorphisms in the Endothelin-1 and Endothelin A Receptor Genes and Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma. Clinical Cancer Research. 17(8). 2451–2458. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026